About Me

I’ve spent 25+ years building in tech, cybersecurity, privacy, and clinical data—across Israeli MedTech startups, Verily, Amgen, and the Fortune 1 company.

Your revenue will stall when your deal logic is broken.

MedTech/TechBio deals don’t die in sales calls. They die when clinical evidence is unclear, workflows are wrong, incentives are misaligned, and a dozen other reasons you missed.

I’m building OpenCRO — the Open Chief Revenue Officer: an AI that diagnoses why your deals don’t close and how to change that.


If you want to reduce deal friction or raise your prices, grab a 15' intro call slot below. —

Book a 15' intro call.
Life Sciences Today podcast

I host in-depth conversations with founders at the intersection of AI, tech and biology. My guests and I reveal the patterns behind sustainable competitive advantages.

Part of the Healthcare IT Today network with a readership of over 100,000 people.

Watch the podcast

Testimonials
Bob and Alice - an anti-love story
  • My latest book is a love story with twists into tech startups and international terror financing.

    Bob and Alice is a thrilling journey into the hearts of two high-performing individuals, each navigating the shadows of their own fears and the demands of their careers. Bob, a Silicon Valley CTO, and Alice, a fiercely dedicated FBI lawyer, find themselves entangled in a web of international intrigue, personal challenges, and the unpredictable currents of love.

    Between high-stakes missions and intimate moments, Bob and Alice explores the profound truth that a relationship thrives when both man and woman share the load, trusting each other to stand strong in their own moments of vulnerability.
Book a call

I’m giving early access to OpenCRO to 50 companies.

OpenCRO — the Open Chief Revenue Officer: an AI that diagnoses why your deals don’t close and how to change that.

If you want to reduce deal friction or raise your prices, grab a 15' intro call slot below.

A short call to see if you're a good fit.


Writing

Building at the intersection of AI, tech and biology and crave clarity?

Clear Thinking has now published 125 consecutive Friday issues — distilling clarity for leaders at the intersection of AI, tech, and biology.

My newsletter shares the patterns and anti-patterns behind high-performing TechBio companies. I draw on 50+ interviews with successful techbio and pharma founders on the Life Sciences Today podcast, plus systematic analysis of my own experiences over 25 years in the space and 5 startups.

The Friday essay is trusted by leaders from Picnic Health, Lindus Health, Menarini, Merck, IQVIA, Medtronic, Flatiron Health, Debiopharm and many more.

We live by My Incomplete Manifesto of 5 core values:

Clarity

We speak plainly. No fluff, no jargon. Strong ideas don’t need gobbledy.

Simplicity

We make complex problems solvable by stripping away what doesn’t matter.

Workmanship

We take pride in what we build. Craft is not a luxury — it’s the job.

Respect

We honor attention. We respect your time. Trust is earned.

Consistency

We show up. Not once. Every time. That’s how progress happens.



Subscribe


Here are some stories you don’t want to miss:
Subscribe